Table 2.
Guidelines for the treatment of bipolar disorder
| |||||||
---|---|---|---|---|---|---|---|
Non-psychotic mania | Mixed mania | Dysphoric mania | Mania with a history of rapid cycling | Euphoric mania | Psychotic mania | Bipolar depression | |
APA | Severe: Li plus AP OR VPA plus AP Less Severe: monotherapy Li, VPA or AP | Li OR VPA | Li OR LAM | ||||
Expert Consensus 2004 | Combination
MS plus AP OR Monotherapy MS |
Combo therapy and monotherapy received equivalent ratings | Combination treatment and monotherapy received equivalent ratings | Combination treatment and monotherapy received equivalent ratings | MS | MS plus AP
OR monotherapy AP |
LAM monotherapy OR LAM plus Li for severe non- psychotic depression with a history of AD-induced mania or rapid cycling |
TMAP | Monotherapy VPA, ARP, RIS, ZIP | Monotherapy Li, VPA, ARP, QTP, RIS, ZIP | LAM plus anti-manic agent if recent and/or severe history of mania, all other patients LAM monotherapy |
Abbreviation: AP, Antipsychotic; MS, Traditional Mood Stabilizer (carbamazepine, divalproex, lithium); Li, Lithium; VPA, Valproate; ARP, Aripiprazole; QTP, Quetiapine; RIS, Risperidone; ZIP, Ziprasidone; LAM, Lamotrigine; AD, Antidepressant.
References: Bowden et al 2002; Keck et al 2004; Suppes et al 2005.